Literature DB >> 7425187

School-based measles outbreaks: correlation of age at immunization with risk of disease.

R G Judelsohn, M L Fleissner, D J O'Mara.   

Abstract

During the Spring of 1978, students with a history of previous measles vaccination accounted for over three-forths of 203 cases of measles in a metropolitan county. Seventy cases occurred in two schools where 99% of the students were vaccinated. We analyzed countywide data to determine past patterns of measles vaccination, including outbreak control and vaccination update clinics. We also examined records of children from the two schools to assess the relationship between disease incidence and age at vaccination. When susceptibility was determined by trained health workers rather than by parents, fewer doses of measles vaccine were estimated to be needed. The majority of cases occurred among children 5 to 9 years old. Attack rates were higher for children vaccinated at 12 months of age or younger than for those vaccinated at 13 months of age or older. There were no significant differences in attack rates among children vaccinated at 13 months of age or older. These findings support recommendations for delaying routine measles vaccination until after 12 months of age and suggest that, during outbreaks, all children vaccinated prior to 13 months of age be revaccinated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7425187      PMCID: PMC1619567          DOI: 10.2105/ajph.70.11.1162

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  Measles epidemic in New Jersey. Vaccine efficacy study in a well-protected population.

Authors:  L Z Ziskin; L G Dimasi
Journal:  J Med Soc N J       Date:  1976-12

2.  Rubella in Bermuda. Termination of an epidemic by mass vaccination.

Authors:  R G Judelsohn; S A Wyll
Journal:  JAMA       Date:  1973-01-22       Impact factor: 56.272

3.  Measles immunization. Successes and failures.

Authors:  A S Yeager; J H Davis; L A Ross; B Harvey
Journal:  JAMA       Date:  1977-01-24       Impact factor: 56.272

4.  Further attenuated live measles vaccines: the need for revised recommendations.

Authors:  R D Krugman; R Rosenberg; K McIntosh; K Herrmann; J J Witte; F A Ennis; B C Meyer
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

5.  Epidemic measles in a highly vaccinated population.

Authors:  D M Shasby; T C Shope; H Downs; K L Herrmann; J Polkowski
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

6.  Measles revaccination. Persistence and degree of antibody titer by type of immune response.

Authors:  J Deseda-Tous; J D Cherry; M J Spencer; R C Welliver; K M Boyer; J P Dudley; J M Zahradnik; P J Krause; E W Walbergh
Journal:  Am J Dis Child       Date:  1978-03

7.  Measles vaccination after exposure to natural measles.

Authors:  O Ruuskanen; T T Salmi; P Halonen
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

8.  Evidence for reinstatement of infants 12 to 14 months of age into routine measles immunization programs.

Authors:  J Wilkins; P F Wehrle
Journal:  Am J Dis Child       Date:  1978-02

9.  A measles outbreak among adolescents.

Authors:  L B Weiner; R M Corwin; P I Nieburg; H A Feldman
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

10.  Airborne spread of measles in a suburban elementary school.

Authors:  E C Riley; G Murphy; R L Riley
Journal:  Am J Epidemiol       Date:  1978-05       Impact factor: 4.897

View more
  2 in total

1.  Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.

Authors:  Sara Carazo; Marie-Noëlle Billard; Amélie Boutin; Gaston De Serres
Journal:  BMC Infect Dis       Date:  2020-03-29       Impact factor: 3.090

2.  Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis.

Authors:  Laura M Nic Lochlainn; Brechje de Gier; Nicoline van der Maas; Peter M Strebel; Tracey Goodman; Rob S van Binnendijk; Hester E de Melker; Susan J M Hahné
Journal:  Lancet Infect Dis       Date:  2019-09-20       Impact factor: 25.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.